Completion of ACTIV-2 Study — ANGEE GREER (PPD DEVELOPMENT LP)
NIAID is sponsoring a clinical research study on novel therapeutics for COVID-19, which is one of the clinical studies for Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV). With an
| Project title | Completion of ACTIV-2 Study |
|---|---|
| Project number | 75N93021D00035-0-759302200002-1 |
| PI name | ANGEE GREER |
| Institution | PPD DEVELOPMENT LP |
| Funding mechanism | N01 |
| Agency | NIAID |
| Award amount | $82.53M |
| Fiscal year | 2022 |
| Project start | 2022-11-06T00:00:00 |
| Project end | 2024-10-31T00:00:00 |
| Abstract | NIAID is sponsoring a clinical research study on novel therapeutics for COVID-19, which is one of the clinical studies for Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV). With an |
| Key terms | <COVID><COVID-19><COVID-19 infection><COVID-19 therapeutics><COVID19><COVID19 infection><COVID19 the |
$799/mo
Try GrantRadar →